Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

US health department proposes three new models to help lower cost of drugs

One suggested model includes offering some essential generic drugs for $2 a month

- PMLiVE

FDA gives orphan drug status to Avidity’s rare muscular dystrophy treatment

There are currently no approved treatments for patients living with the disease

- PMLiVE

Declining disruption

Innovation may be becoming less innovative

- PMLiVE

MSD’s Keytruda plus chemotherapy approved in Scotland for advanced cervical cancer

There were around 604,000 new cases and 342,000 deaths in 2020 from cervical cancer

- PMLiVE

BMS, Exelixis and Ipsen report three-year results for combination treatment in kidney cancer

Renal cell carcinoma accounts for more than 431,000 new cases and 179,000 deaths each year

EU flag

EC approves UCB’s Fintepla to treat severe form of epilepsy

Lennox-Gastaut syndrome affects around two in 10,000 people in the EU and usually begins in early childhood

- PMLiVE

Havas Health & You appoints Alex Okada as chief creative officer of Havas Lynx Group

Okada was most recently executive creative director for international accounts at MullenLowe

- PMLiVE

The state of pharma customer experience

New research reveals the industry’s customer experience leaders and laggards in the evolving post-COVID-19 hybrid environment

OPEN Health to acquire Acsel Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

OPEN Health

- PMLiVE

Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer

Around 790 people are diagnosed with acute lymphoblastic leukaemia each year in the UK

- PMLiVE

Pfizer/BioNTech initiate study of first mRNA shingles vaccine candidates

Around 95% of people over the age of 50 have been exposed to the virus that causes shingles

- PMLiVE

BMS and 2seventy bio report positive phase 3 results for multiple myeloma treatment

An estimated 35,000 new cases of multiple myeloma will be diagnosed in the US this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links